Figure 2.

Percentage of patients achieving normal CD3, CD8, CD4, and CD19 counts, and responses to PHA stimulation. Data at 4 months are shown in panel A and 6 months in panel B.

Percentage of patients achieving normal CD3, CD8, CD4, and CD19 counts, and responses to PHA stimulation. Data at 4 months are shown in panel A and 6 months in panel B.